153 related articles for article (PubMed ID: 23942796)
1. The prognostic significance of Jun transcription factors in ovarian cancer.
Eckhoff K; Flurschütz R; Trillsch F; Mahner S; Jänicke F; Milde-Langosch K
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1673-80. PubMed ID: 23942796
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J
Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer.
Qiu JJ; Guo JJ; Lv TJ; Jin HY; Ding JX; Feng WW; Zhang Y; Hua KQ
Tumour Biol; 2013 Oct; 34(5):2971-5. PubMed ID: 23712606
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
6. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
[TBL] [Abstract][Full Text] [Related]
7. C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.
Mahner S; Baasch C; Schwarz J; Hein S; Wölber L; Jänicke F; Milde-Langosch K
Br J Cancer; 2008 Oct; 99(8):1269-75. PubMed ID: 18854825
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
Huang YW; Chen C; Xu MM; Li JD; Xiao J; Zhu XF
Mol Cell Biochem; 2013 Apr; 376(1-2):73-9. PubMed ID: 23277333
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.
Lundgren S; Berntsson J; Nodin B; Micke P; Jirström K
J Ovarian Res; 2016 Apr; 9():21. PubMed ID: 27048364
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of GRIM-19 in epithelial ovarian carcinoma].
Shao YP; Cheng XD; Wan XY
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):751-5. PubMed ID: 23302733
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
[TBL] [Abstract][Full Text] [Related]
12. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.
Omichi C; Nakamura K; Haraga J; Masuyama H; Hiramatsu Y
Cancer Med; 2016 Jun; 5(6):1074-80. PubMed ID: 26929186
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
Shuang T; Wang M; Zhou Y; Shi C
Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
[TBL] [Abstract][Full Text] [Related]
14. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of cortactin protein in ovarian neoplasms.
Li A; Zhang L; Zhang X; Jin W; Ren Y
Clin Transl Oncol; 2016 Feb; 18(2):220-7. PubMed ID: 26243395
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma.
Meng F; Luo C; Ma L; Hu Y; Lou G
Int J Gynecol Pathol; 2011 Mar; 30(2):145-50. PubMed ID: 21293286
[TBL] [Abstract][Full Text] [Related]
17. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
Peng DX; Luo M; Qiu LW; He YL; Wang XF
Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
20. Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study.
Heeran MC; Rask L; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Jarle Christensen IB; Høgdall EV
APMIS; 2015 May; 123(5):401-9. PubMed ID: 25846370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
